Literature DB >> 28526550

Impact of First Eye versus Second Eye Cataract Surgery on Visual Function and Quality of Life.

Nakul S Shekhawat1, Michael V Stock2, Elizabeth F Baze3, Mary K Daly4, David E Vollman2, Mary G Lawrence5, Amy S Chomsky6.   

Abstract

PURPOSE: To compare the impact of first eye versus second eye cataract surgery on visual function and quality of life.
DESIGN: Cohort study. PARTICIPANTS: A total of 328 patients undergoing separate first eye and second eye phacoemulsification cataract surgeries at 5 veterans affairs centers in the United States. Patients with previous ocular surgery, postoperative endophthalmitis, postoperative retinal detachment, reoperation within 30 days, dementia, anxiety disorder, hearing difficulty, or history of drug abuse were excluded.
METHODS: Patients received complete preoperative and postoperative ophthalmic examinations for first eye and second eye cataract surgeries. Best-corrected visual acuity (BCVA) was measured 30 to 90 days preoperatively and postoperatively. Patients completed the National Eye Institute Visual Functioning Questionnaire (NEI-VFQ) 30 to 90 days preoperatively and postoperatively. The NEI-VFQ scores were calculated using a traditional subscale scoring algorithm and a Rasch-refined approach producing visual function and socioemotional subscale scores. MAIN OUTCOME MEASURES: Postoperative NEI-VFQ scores and improvement in NEI-VFQ scores comparing first eye versus second eye cataract surgery.
RESULTS: Mean age was 70.4 years (±9.6 standard deviation [SD]). Compared with second eyes, first eyes had worse mean preoperative BCVA (0.55 vs. 0.36 logarithm of the minimum angle of resolution (logMAR), P < 0.001), greater mean BCVA improvement after surgery (-0.50 vs. -0.32 logMAR, P < 0.001), and slightly worse postoperative BCVA (0.06 vs. 0.03 logMAR, P = 0.039). Compared with first eye surgery, second eye surgery resulted in higher postoperative NEI-VFQ scores for nearly all traditional subscales (P < 0.001), visual function subscale (-3.85 vs. -2.91 logits, P < 0.001), and socioemotional subscale (-2.63 vs. -2.10 logits, P < 0.001). First eye surgery improved visual function scores more than second eye surgery (-2.99 vs. -2.67 logits, P = 0.021), but both first and second eye surgeries resulted in similar improvements in socioemotional scores (-1.62 vs. -1.51 logits, P = 0.255).
CONCLUSIONS: Second eye cataract surgery improves visual function and quality of life well beyond levels achieved after first eye cataract surgery alone. For certain socioemotional aspects of quality of life, second eye cataract surgery results in comparable improvement to first eye cataract surgery.
Copyright © 2017 American Academy of Ophthalmology. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28526550     DOI: 10.1016/j.ophtha.2017.04.014

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Association of Social Support Network Size With Receipt of Cataract Surgery in Older Adults.

Authors:  Brian C Stagg; HwaJung Choi; Maria A Woodward; Joshua R Ehrlich
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

Review 2.  Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts.

Authors:  Mor M Dickman; Lindsay S Spekreijse; Bjorn Winkens; Johannes Sag Schouten; Rob Wp Simons; Carmen D Dirksen; Rudy Mma Nuijts
Journal:  Cochrane Database Syst Rev       Date:  2022-04-25

3.  Refractive outcomes following cataract surgery in patients who have had myopic laser vision correction.

Authors:  Chung Shen Chean; Boon Kang Aw Yong; Samuel Comely; Deena Maleedy; Stephen Kaye; Mark Batterbury; Vito Romano; Esmaeil Arbabi; Victor Hu
Journal:  BMJ Open Ophthalmol       Date:  2019-04-09

4.  Cost-effectiveness of immediate versus delayed sequential bilateral cataract surgery in the Netherlands (the BICAT-NL study): study design of a prospective multicenter randomised controlled trial.

Authors:  L S Spekreijse; R W P Simons; B Winkens; F J H M van den Biggelaar; C D Dirksen; R M M A Nuijts
Journal:  BMC Ophthalmol       Date:  2020-06-29       Impact factor: 2.209

5.  The impact of first and second eye cataract surgeries on falls: a prospective cohort study.

Authors:  Ying Ru Feng; Lynn B Meuleners; Michelle L Fraser; Kate J Brameld; Seraina Agramunt
Journal:  Clin Interv Aging       Date:  2018-08-23       Impact factor: 4.458

6.  Predicting changes in cataract surgery health outcomes using a cataract surgery appropriateness and prioritization instrument.

Authors:  Morgan E Lim; Simona C Minotti; Chelsea D'Silva; Robert J Reid; Matthew B Schlenker; Iqbal K Ahmed
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

7.  Implementing ICHOM standard set for cataract surgery at IPO-Porto (Portugal): clinical outcomes, quality of life and costs.

Authors:  Lara Queirós; Patrícia Redondo; M França; Sérgio Estrela Silva; Pedro Borges; António Benevides de Melo; Nuno Pereira; Paulo Freitas da Costa; Nazaré Carvalho; Marina Borges; Isabel Sequeira; Francisco Nuno Rocha Gonçalves; José Lemos
Journal:  BMC Ophthalmol       Date:  2021-03-05       Impact factor: 2.209

8.  The impact of phacoemulsification surgery on vision-related quality of life in senile cataract patients.

Authors:  Cetin Akpolat; Mehmet Demir; Seval Cevher; Sibel Zorlu Ozturk; Sumeyra Yesiltas
Journal:  Ther Adv Ophthalmol       Date:  2022-01-21

9.  Surgical planning during a pandemic: Identifying patients at high risk of severe disease or death due to COVID-19 in a cohort of patients on a cataract surgery waiting list.

Authors:  Mark Stuart; Ciaran Mooney; Monica Hrabovsky; Giuliana Silvestri; Stephen Stewart
Journal:  Ulster Med J       Date:  2022-02-11

10.  Association of Visual Impairment With Risk of Incident Dementia in a Women's Health Initiative Population.

Authors:  Elaine M Tran; Marcia L Stefanick; Victor W Henderson; Stephen R Rapp; Jiu-Chiuan Chen; Nicole M Armstrong; Mark A Espeland; Emily W Gower; Aladdin H Shadyab; Wenjun Li; Katie L Stone; Suzann Pershing
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.